CVE:VIR Viridium Pacific Group (VIR) Stock Price, News & Analysis C$0.38 +0.02 (+5.56%) (As of 06/7/2019) Add Compare Share Share Today's RangeC$0.37▼C$0.4150-Day RangeC$0.38▼C$0.3852-Week RangeC$0.36▼C$1.15Volume26,500 shsAverage Volume92,632 shsMarket CapitalizationC$37.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Viridium Pacific Group alerts: Email Address Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade About Viridium Pacific Group Stock (CVE:VIR)Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.Read More VIR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VIR Stock News HeadlinesSeptember 5 at 2:51 AM | americanbankingnews.comViridium Pacific Group (CVE:VIR) Shares Up 5.6%September 4 at 10:17 PM | newsweek.comTaiwan Erased From Pacific Summit After Chinese AngerSeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 27, 2024 | msn.comMassive Void Emerges In Pacific As US Shuffles Warships To Middle EastAugust 9, 2024 | msn.comSEC Fines Pacific Financial Group for Alleged Marketing Rule ViolationsAugust 6, 2024 | seekingalpha.comUnion Pacific: A Blue Chip Dividend Stock To Board NowMay 24, 2024 | msn.comPacific Wrecks Team Locates What They Believe to Be Richard Bong's Missing P-38 'Marge'May 8, 2024 | markets.businessinsider.comPan Pacific London introduces the Singa Cub ClubSeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.May 8, 2024 | msn.com3 big energy players ink ‘VIP’ pact; green group cynicalMay 2, 2024 | ft.comLive news: Sony and Apollo express interest in $26bn Paramount bidApril 26, 2024 | seekingalpha.comVena Magic! Why Union Pacific Just Hit A Grand SlamApril 18, 2024 | latimes.comWith new ammunition pier open, Seal Beach can help surge warships to Pacific hotspotsApril 10, 2024 | msn.comUSS Boxer Ready Group Finally Deploys with 15th MEU from Camp PendletonApril 9, 2024 | msn.comSwire Pacific Limited goes ex dividend tomorrowJanuary 9, 2024 | msn.comPacific Drive already feels like a brilliant mix of the road, the radio, and roguelikeDecember 17, 2023 | bbc.comCoronavirus: Cathay Pacific gets $5bn state-backed bailoutSeptember 20, 2023 | msn.comCentury Pacific, Woolworths partnerSee More Headlines Receive VIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viridium Pacific Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolCVE:VIR CUSIPN/A CIKN/A Webwww.viridiumpacific.com Phone604-837-8688FaxN/AEmployees580Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio10.28 Quick Ratio9.91 Sales & Book Value Annual SalesC$1.09 million Price / Sales34.46 Cash FlowC$0.13 per share Price / Cash Flow2.92 Book ValueC$0.29 per share Price / Book1.30Miscellaneous Outstanding Shares98,733,000Free FloatN/AMarket CapC$37.52 million OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Jay Garnett (Age 50)Pres, CEO & Director Mr. Jarrett Malnarick (Age 46)Sr. VP, COO & Director Ms. Sze Wan Wong C.A. (Age 45)CPA, CA, CPA, Corp. Sec. & Strategic Advisor Ms. Kamini HitkariChief Financial OfficerMr. Bob HowardExec. OfficerKey CompetitorsAndean Precious MetalsCVE:APMInternational Tower Hill MinesTSE:ITHGraphite OneCVE:GPHEQCVE:EQWeedMDCVE:WMDView All Competitors VIR Stock Analysis - Frequently Asked Questions How have VIR shares performed this year? Viridium Pacific Group's stock was trading at C$0.38 at the start of the year. Since then, VIR shares have increased by 0.0% and is now trading at C$0.38. View the best growth stocks for 2024 here. How do I buy shares of Viridium Pacific Group? Shares of VIR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Viridium Pacific Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Viridium Pacific Group investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Baytex Energy (BTE), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX). This page (CVE:VIR) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridium Pacific Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridium Pacific Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VIR Stock Alerts